8-K current report · filed Oct 23, 2026

Ardent Health, Inc. (ARDT) 8-K Current Report: October 23, 2026

Item 5.02ARDT overview

Short answer

Ardent Health, Inc. (ARDT) filed an 8-K current report with the SEC on October 23, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Former CEO Martin Bonick’s separation reclassified as termination for Cause after Board review.

Ardent Health, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Former CEO Martin Bonick’s separation reclassified as termination for Cause after Board review
  • Board cited undisclosed third-party compensation, raising governance and executive oversight concerns
  • Approximately $4.5 million unpaid cash severance discontinued
  • Outstanding unvested performance-based restricted stock units cancelled or forfeited
  • Company reserved rights to pursue additional remedies; prior financial statements unaffected

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Ardent Health, Inc. 8-K filings

Get the next ARDT 8-K as it lands

Follow ARDT for push alerts, or ask the research agent what this filing means.